The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 05, 2016
Filed:
Mar. 04, 2008
Applicants:
Claire Rodriguez-lafrasse, Venissieux, FR;
Elie Hadchity, Lyons, FR;
Inventors:
Claire Rodriguez-Lafrasse, Venissieux, FR;
Elie Hadchity, Lyons, FR;
Assignee:
The University of British Columbia, Vancouver, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 31/712 (2006.01); A01K 67/027 (2006.01); A61K 31/7088 (2006.01); A61K 31/7125 (2006.01);
U.S. Cl.
CPC ...
A61K 31/712 (2013.01); A01K 67/0271 (2013.01); A61K 31/7088 (2013.01); A61K 31/7125 (2013.01); A01K 2207/05 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0331 (2013.01);
Abstract
Squamous cell carcinomas, such as squamous head and neck cancer, are treated with a combination of radio-therapy and a therapeutic agent that reduces the amount of hsp27 in the squamous cancer cells. In specific embodiments, the therapeutic agent that reduces the amount of hsp27 is an antisense oligonucleotide therapeutic agent.
Rodriguez-Lafrasse, Claire. (2016). Treatment of squamous cell carcinoma with hsp27 antisense oligonucleotides and radiotherapy (U.S. Patent No. 9381209). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9381209
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile